Tissue engineering strategies in spinal arthrodesis: The clinical imperative and challenges to clinical translation

Regenerative Medicine

Volumn 8, Issue 1, 2013, Pages 49-64

  Evans, Nick R ^a   Davies, Evan M ^a   Dare, Chris J ^a   Oreffo, Richard O C ^a,b  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

autograft; bone graft substitute; clinical translation; fusion; mesenchymal stem cell; osteogenesis; spinal arthrodesis; tissue engineering

Indexed keywords

CYTOKINE; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; INTERLEUKIN 1; PLATELET DERIVED GROWTH FACTOR; RECOMBINANT GROWTH FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA;

ARTHRODESIS; ARTHROPATHY; BONE DEVELOPMENT; BONE GRAFT; CONTROLLED STUDY; GENE THERAPY; HUMAN; IMMUNOGENICITY; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; REVIEW; SPINAL ARTHRODESIS; SPINE FUSION; TISSUE ENGINEERING;

ANIMALS; BONE SUBSTITUTES; BONE TRANSPLANTATION; HUMANS; SPINAL FUSION; TISSUE ENGINEERING; TRANSLATIONAL MEDICAL RESEARCH; TRANSPLANTATION, AUTOLOGOUS;

EID: 84871584736     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.12.106     Document Type: Review

References (139)

1. Yoon ST, Boden SD. Spine fusion by gene therapy. Gene Ther. 11(4), 360-367 (2004).
2. Depalma AF, Rothman RH. The nature of pseudarthrosis. Clin. Orthop. Relat. Res. 59, 113-118 (1968).
3. Steinmann JC, Herkowitz HN. Pseudarthrosis of the spine. Clin. Orthop. Relat. Res. (284), 80-90 (1992).
4. Dimitriou R, Mataliotakis GI, Angoules AG, Kanakaris NK, Giannoudis PV. Complications following autologous bone graft harvesting from the iliac crest and using the RIA: a systematic review. Injury 42(Suppl. 2), S3-S15 (2011).
5. Jorgenson SS, Lowe TG, France J, Sabin J. A prospective analysis of autograft versus allograft in posterolateral lumbar fusion in the same patient. A minimum of 1-year follow-up in 144 patients. Spine 19(18), 2048-2053 (1994).
6. Bishop RC, Moore KA, Hadley MN. Anterior cervical interbody fusion using autogeneic and allogeneic bone graft substrate: a prospective comparative analysis. J. Neurosurg. 85(2), 206-210 (1996).
7. Malinen TI, Brown MD. Bone allografts in spine surgery. Clin. Orthop. Relat. Res. (154), 68-73 (1981).
8. Urist MR. Bone: formation by autoinduction. Science 150(3698), 893-899 (1965).
9. Guizzardi S, Di Silvestre M, Scandroglio R, Ruggeri A, Savini R. Implants of heterologous demineralized bone matrix for induction of posterior spinal fusion in rats. Spine 17(6), 701-707 (1992).
10. Wildemann B, Kadow-Romacker A, Haas NP, Schmidmaier G. Quantification of various growth factors in different demineralized bone matrix preparations. J. Biomed. Mater. Res. Part A 81(2), 437-442 (2007).
11. Bae HW, Zhao L, Kanim LE, Wong P, Delamarter RB, Dawson EG. Intervariability and intravariability of bone morphogenetic proteins in commercially available demineralized bone matrix products. Spine 31(12), 1299-1306; discussion 1307-1298 (2006).
12. Lee KJ, Roper JG, Wang JC. Demineralized bone matrix and spinal arthrodesis. Spine J. 5(6 Suppl. ), 217S-223S (2005).
13. Wang J, Glimcher MJ. Characterization of matrix-induced osteogenesis in rat calvarial bone defects: II. Origins of bone-forming cells. Calcif. Tissue Int. 65(6), 486-493 (1999).
14. Wang J, Glimcher MJ. Characterization of matrix-induced osteogenesis in rat calvarial bone defects: I. Differences in the cellular response to demineralized bone matrix implanted in calvarial defects and in subcutaneous sites. Calcif. Tissue Int. 65(2), 156-165 (1999).
15. Wang J, Yang R, Gerstenfeld LC, Glimcher MJ. Characterization of demineralized bone matrix-induced osteogenesis in rat calvarial bone defects: III. Gene and protein expression. Calcif. Tissue Int. 67(4), 314-320 (2000).
16. An HS, Simpson JM, Glover JM, Stephany J. Comparison between allograft plus demineralized bone matrix versus autograft in anterior cervical fusion. A prospective multicenter study. Spine 20(20), 2211-2216 (1995).
17. Russell JL, Block JE. Clinical utility of demineralized bone matrix for osseous defects, arthrodesis, and reconstruction: impact of processing techniques and study methodology. Orthopedics 22(5), 524-531; quiz 532-523 (1999).
18. Rihn JA, Kirkpatrick K, Albert TJ. Graft options in posterolateral and posterior interbody lumbar fusion. Spine 35(17), 1629-1639 (2010).
19. Chau AM, Mobbs RJ. Bone graft substitutes in anterior cervical discectomy and fusion. Eur. Spine J. 18(4), 449-464 (2009).
20. Kwon B, Jenis LG. Carrier materials for spinal fusion. Spine J. 5(6 Suppl. ), 224S-230S (2005).
21. Brandoff JF, Silber JS, Vaccaro AR. Contemporary alternatives to synthetic bone grafts for spine surgery. Am. J. Orthop. 37(8), 410-414 (2008).
22. Vaccaro AR, Chiba K, Heller JG et al. Bone grafting alternatives in spinal surgery. Spine J. 2(3), 206-215 (2002).
23. Helm GA, Dayoub H, Jane JA Jr. Bone graft substitutes for the promotion of spinal arthrodesis. Neurosurg. Focus 10(4), E4 (2001).
24. Miyazaki M, Tsumura H, Wang JC, Alanay A. An update on bone substitutes for spinal fusion. Eur. Spine J. 18(6), 783-799 (2009).
25. Blanco JF, Sanchez-Guijo FM, Carrancio S, Muntion S, Garcia-Brinon J, Del Canizo MC. Titanium and tantalum as mesenchymal stem cell scaffolds for spinal fusion: an in vitro comparative study. Eur. Spine J. 20(Suppl. 3), 353-360 (2011).
26. Blattert TR, Delling G, Dalal PS, Toth CA, Balling H, Weckbach A. Successful transpedicular lumbar interbody fusion by means of a composite of osteogenic protein-1 (rhBMP-7) and hydroxyapatite carrier: a comparison with autograft and hydroxyapatite in the sheep spine. Spine 27(23), 2697-2705 (2002).
27. Boden SD, Martin GJ Jr, Morone MA, Ugbo JL, Moskovitz PA. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine 24(12), 1179-1185 (1999).
28. Boden SD, Kang J, Sandhu H, Heller JG. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine 27(23), 2662-2673 (2002).
29. Boden SD, Zdeblick TA, Sandhu HS, Heim SE. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 25(3), 376-381 (2000).
30. Burkus JK, Gornet MF, Dickman CA, Zdeblick TA. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J. Spinal Disord. Tech. 15(5), 337-349 (2002).
31. Garrison KR, Donell S, Ryder J et al. Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review. Health Technol. Assess. 11(30), 1-150, iii-iv (2007).
32. Boden SD, Schimandle JH, Hutton WC. 1995 Volvo Award in basic sciences. The use of an osteoinductive growth factor for lumbar spinal fusion. Part II: study of dose, carrier, and species. Spine 20(24), 2633-2644 (1995).
33. Mroz TE, Wang JC, Hashimoto R, Norvell DC. Complications related to osteobiologics use in spine surgery: a systematic review. Spine 35(9 Suppl. ), S86-S104 (2010).
34. Romih M, Delecrin J, Heymann D, Passuti N. The vertebral interbody grafting site's low concentration in osteogenic progenitors can greatly benefit from addition of iliac crest bone marrow. Eur. Spine J. 14(7), 645-648 (2005).
35. Tanaka K, Takemoto M, Fujibayashi S, Neo M, Shikinami Y, Nakamura T. A bioactive and bioresorbable porous cubic composite scaffold loaded with bone marrow aspirate: a potential alternative to autogenous bone grafting. Spine 36(6), 441-447 (2011).
36. Koga A, Tokuhashi Y, Ohkawa A, Nishimura T, Takayama K, Ryu J. Effects of fibronectin on osteoinductive capability of fresh iliac bone marrow aspirate in posterolateral spinal fusion in rabbits. Spine 33(12), 1318-1323 (2008).
37. Gupta MC, Theerajunyaporn T, Maitra S et al. Efficacy of mesenchymal stem cell enriched grafts in an ovine posterolateral lumbar spine model. Spine 32(7), 720-726; discussion 727 (2007).
38. Kraiwattanapong C, Boden SD, Louis-Ugbo J, Attallah E, Barnes B, Hutton WC. Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion. Spine 30(9), 1001-1007 (2005).
39. Muschler GF, Matsukura Y, Nitto H et al. Selective retention of bone marrow-derived cells to enhance spinal fusion. Clin. Orthop. Relat. Res. (432), 242-251 (2005).
40. Curylo LJ, Johnstone B, Petersilge CA, Janicki JA, Yoo JU. Augmentation of spinal arthrodesis with autologous bone marrow in a rabbit posterolateral spine fusion model. Spine 24(5), 434-438 (1999).
41. Boden SD, Martin GJ Jr, Morone M, Ugbo JL, Titus L, Hutton WC. The use of coralline hydroxyapatite with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion. Spine 24(4), 320-327 (1999).
42. Tay BK, Le AX, Heilman M, Lotz J, Bradford DS. Use of a collagen-hydroxyapatite matrix in spinal fusion. A rabbit model. Spine 23(21), 2276-2281 (1998).
43. Yamada T, Yoshii T, Sotome S et al. Hybrid grafting using bone marrow aspirate combined with porous beta-tricalcium phosphate and trephine bone for lumbar posterolateral spinal fusion: a prospective, comparative study versus local bone grafting. Spine 37(3), E174-E179 (2012).
44. Kerr EJ 3rd, Jawahar A, Wooten T, Kay S, Cavanaugh DA, Nunley PD. The use of osteo-conductive stem-cells allograft in lumbar interbody fusion procedures: an alternative to recombinant human bone morphogenetic protein. J. Surg. Orthop. Adv. 20(3), 193-197 (2011).
45. Taghavi CE, Lee KB, Keorochana G, Tzeng ST, Yoo JH, Wang JC. Bone morphogenetic protein-2 and bone marrow aspirate with allograft as alternatives to autograft in instrumented revision posterolateral lumbar spinal fusion: a minimum two-year follow-up study. Spine 35(11), 1144-1150 (2010).
46. Niu CC, Tsai TT, Fu TS, Lai PL, Chen LH, Chen WJ. A comparison of posterolateral lumbar fusion comparing autograft, autogenous laminectomy bone with bone marrow aspirate, and calcium sulphate with bone marrow aspirate: a prospective randomized study. Spine 34(25), 2715-2719 (2009).
47. Gan Y, Dai K, Zhang P, Tang T, Zhu Z, Lu J. The clinical use of enriched bone marrow stem cells combined with porous beta-tricalcium phosphate in posterior spinal fusion. Biomaterials 29(29), 3973-3982 (2008).
48. Zhang P, Gan YK, Tang J et al. [Clinical study of lumbar fusion by hybrid construct of stem cells technique and biodegradable material]. Zhonghua Wai Ke Za Zhi 46(7), 493-496 (2008).
49. Neen D, Noyes D, Shaw M, Gwilym S, Fairlie N, Birch N. Healos and bone marrow aspirate used for lumbar spine fusion: a case controlled study comparing healos with autograft. Spine 31(18), E636-E640 (2006).
50. Kitchel SH, Wang MY, Lauryssen CL. Techniques for aspirating bone marrow for use in spinal surgery. Neurosurgery 57(4 Suppl. ), 286-289; discussion 286-289 (2005).
51. Muschler GF, Boehm C, Easley K. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. J. Bone Joint Surg. Am. 79(11), 1699-1709 (1997).
52. Mclain RF, Fleming JE, Boehm CA, Muschler GF. Aspiration of osteoprogenitor cells for augmenting spinal fusion: comparison of progenitor cell concentrations from the vertebral body and iliac crest. J. Bone Joint Surg. Am. 87(12), 2655-2661 (2005).
53. Mclain RF, Boehm CA, Rufo-Smith C, Muschler GF. Transpedicular aspiration of osteoprogenitor cells from the vertebral body: progenitor cell concentrations affected by serial aspiration. Spine J. 9(12), 995-1002 (2009).
54. Min WK, Bae JS, Park BC et al. Proliferation and osteoblastic differentiation of bone marrow stem cells: comparison of vertebral body and iliac crest. Eur. Spine J. 19(10), 1753-1760 (2010).
55. Risbud MV, Shapiro IM, Guttapalli A et al. Osteogenic potential of adult human stem cells of the lumbar vertebral body and the iliac crest. Spine 31(1), 83-89 (2006).
56. Connolly J, Guse R, Lippiello L, Dehne R. Development of an osteogenic bone-marrow preparation. J. Bone Joint Surg. Am. 71(5), 684-691 (1989).
57. Muschler GF, Nitto H, Matsukura Y et al. Spine fusion using cell matrix composites enriched in bone marrow-derived cells. Clin. Orthop. Relat. Res. 407, 102-118 (2003).
58. Tateishi-Yuyama E, Matsubara H, Murohara T et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360(9331), 427-435 (2002).
59. Jacobsen K, Szczepanowski K, Al-Zube LA, Kim J, Lin SS. The role of intraoperative bone marrow aspirate stem cell concentration as a bone grafting technique. Tech. Foot Ankle Surg. 7(2), 84-89 (2008).
60. Yang W, Dong Y, Hong Y, Guang Q, Chen X. Evaluation of anterior vertebral interbody fusion using osteogenic mesenchymal stem cells transplanted in collagen sponge. J. Spinal Disord. Tech. doi:10. 1097/BSD. 0b013e31825ca123 (2012) (Epub ahead of print).
61. Abbah SA, Lam CX, Ramruttun AK, Goh JC, Wong HK. Fusion performance of low-dose recombinant human bone morphogenetic protein 2 and bone marrow-derived multipotent stromal cells in biodegradable scaffolds: a comparative study in a large animal model of anterior lumbar interbody fusion. Spine 36(21), 1752-1759 (2011).
62. Hui CF, Chan CW, Yeung HY et al. Low-intensity pulsed ultrasound enhances posterior spinal fusion implanted with mesenchymal stem cells-calcium phosphate composite without bone grafting. Spine 36(13), 1010-1016 (2011).
63. Huang JW, Lin SS, Chen LH et al. The use of fluorescence-labeled mesenchymal stem cells in poly(lactide-co-glycolide)/hydroxyapatite/collagen hybrid graft as a bone substitute for posterolateral spinal fusion. J. Trauma 70(6), 1495-1502 (2011).
64. Goldschlager T, Rosenfeld JV, Ghosh P et al. Cervical interbody fusion is enhanced by allogeneic mesenchymal precursor cells in an ovine model. Spine 36(8), 615-623 (2011).
65. Urrutia J, Mery P, Martinez R, Pizarro F, Apablaza D, Mardones R. Cultured autologous bone marrow stem cells inhibit bony fusion in a rabbit model of posterolateral lumbar fusion with autologous bone graft. J. Clin. Neurosci. 17(4), 481-485 (2010).
66. Seo HS, Jung JK, Lim MH, Hyun DK, Oh NS, Yoon SH. Evaluation of spinal fusion using bone marrow derived mesenchymal stem cells with or without fibroblast growth factor-4. J. Korean Neurosurg. Soc. 46(4), 397-402 (2009).
67. Chen WJ, Huang JW, Niu CC et al. Use of fluorescence labeled mesenchymal stem cells in pluronic F127 and porous hydroxyapatite as a bone substitute for posterolateral spinal fusion. J. Orthop. Res. 27(12), 1631-1636 (2009).
68. Fu TS, Chen WJ, Chen LH, Lin SS, Liu SJ, Ueng SW. Enhancement of posterolateral lumbar spine fusion using low-dose rhBMP-2 and cultured marrow stromal cells. J. Orthop. Res. 27(3), 380-384 (2009).
69. Valdes M, Moore DC, Palumbo M et al. rhBMP-6 stimulated osteoprogenitor cells enhance posterolateral spinal fusion in the New Zealand white rabbit. Spine J. 7(3), 318-325 (2007).
70. Minamide A, Yoshida M, Kawakami M et al. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion. Spine 32(10), 1067-1071 (2007).
71. Nakajima T, Iizuka H, Tsutsumi S, Kayakabe M, Takagishi K. Evaluation of posterolateral spinal fusion using mesenchymal stem cells: differences with or without osteogenic differentiation. Spine 32(22), 2432-2436 (2007).
72. Wang T, Dang G, Guo Z, Yang M. Evaluation of autologous bone marrow mesenchymal stem cell-calcium phosphate ceramic composite for lumbar fusion in rhesus monkey interbody fusion model. Tissue Eng. 11(7-8), 1159-1167 (2005).
73. Tan KK, Tan GH, Shamsul BS et al. Bone graft substitute using hydroxyapatite scaffold seeded with tissue engineered autologous osteoprogenitor cells in spinal fusion: early result in a sheep model. Med. J. Malaysia 60(Suppl. C), 53-58 (2005).
74. Minamide A, Yoshida M, Kawakami M et al. The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion. Spine 30(10), 1134-1138 (2005).
75. Orii H, Sotome S, Chen J, Wang J, Shinomiya K. Beta-tricalcium phosphate (beta-TCP) graft combined with bone marrow stromal cells (MSCs) for posterolateral spine fusion. J. Med. Dental Sci. 52(1), 51-57 (2005).
76. Cinotti G, Patti AM, Vulcano A et al. Experimental posterolateral spinal fusion with porous ceramics and mesenchymal stem cells. J. Bone Joint Surg. Br. 86(1), 135-142 (2004).
77. Kai T, Shao-Qing G, Geng-Ting D. In vivo evaluation of bone marrow stromal-derived osteoblasts-porous calcium phosphate ceramic composites as bone graft substitute for lumbar intervertebral spinal fusion. Spine 28(15), 1653-1658 (2003).
78. Cui Q, Ming Xiao Z, Balian G, Wang GJ. Comparison of lumbar spine fusion using mixed and cloned marrow cells. Spine 26(21), 2305-2310 (2001).
79. Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp. Hematol. 28(6), 707-715 (2000).
80. Chen J, Sotome S, Wang J, Orii H, Uemura T, Shinomiya K. Correlation of in vivo bone formation capability and in vitro differentiation of human bone marrow stromal cells. J. Med. Dental Sci. 52(1), 27-34 (2005).
81. Halvorsen YC, Wilkison WO, Gimble JM. Adipose-derived stromal cells-their utility and potential in bone formation. Int. J. Obes. Relat. Metab. Disord. 24(Suppl. 4), S41-S44 (2000).
82. Levi B, Longaker MT. Concise review: adipose-derived stromal cells for skeletal regenerative medicine. Stem Cells 29(4), 576-582 (2011).
83. Breitbart AS, Grande DA, Kessler R, Ryaby JT, Fitzsimmons RJ, Grant RT. Tissue engineered bone repair of calvarial defects using cultured periosteal cells. Plast. Reconstr. Surg. 101(3), 567-574 (1998).
84. Lee JY, Musgrave D, Pelinkovic D et al. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J. Bone Joint Surg. Am. 83(7), 1032-1039 (2001).
85. Lopez MJ, Mcintosh KR, Spencer ND et al. Acceleration of spinal fusion using syngeneic and allogeneic adult adipose derived stem cells in a rat model. J. Orthop. Res. 27(3), 366-373 (2009).
86. Vergroesen PP, Kroeze RJ, Helder MN, Smit TH. The use of poly(l-lactide-co-caprolactone) as a scaffold for adipose stem cells in bone tissue engineering: application in a spinal fusion model. Macromol. Biosci. 11(6), 722-730 (2011).
87. Tang ZB, Cao JK, Wen N et al. Posterolateral spinal fusion with nano-hydroxyapatite-collagen/PLA composite and autologous adipose-derived mesenchymal stem cells in a rabbit model. J. Tissue Eng. Regen. Med. 6(4), 325-336 (2012).
88. Gottfried ON, Dailey AT. Mesenchymal stem cell and gene therapies for spinal fusion. Neurosurgery 63(3), 380-391; discussion 391-382 (2008).
89. Aslan H, Sheyn D, Gazit D. Genetically engineered mesenchymal stem cells: applications in spine therapy. Regen. Med. 4(1), 99-108 (2009).
90. Pneumaticos SG, Triantafyllopoulos GK, Chatziioannou S, Basdra EK, Papavassiliou AG. Biomolecular strategies of bone augmentation in spinal surgery. Trends Mol. Med. 17(4), 215-222 (2011).
91. Cha CW, Boden SD. Gene therapy applications for spine fusion. Spine 28(15 Suppl. ), S74-S84 (2003).
92. Rubery PT. Enhancing allograft bone healing through gene therapy. Spine 35(17), 1640-1647 (2010).
93. Helm GA, Alden TD, Beres EJ et al. Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent. J. Neurosurg. 92(2 Suppl. ), 191-196 (2000).
94. Laurent JJ, Webb KM, Beres EJ et al. The use of bone morphogenetic protein-6 gene therapy for percutaneous spinal fusion in rabbits. J. Neurosurg. Spine 1(1), 90-94 (2004).
95. Alden TD, Pittman DD, Beres EJ et al. Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy. J. Neurosurg. 90(1 Suppl. ), 109-114 (1999).
96. Hasharoni A, Zilberman Y, Turgeman G, Helm GA, Liebergall M, Gazit D. Murine spinal fusion induced by engineered mesenchymal stem cells that conditionally express bone morphogenetic protein-2. J. Neurosurg. Spine 3(1), 47-52 (2005).
97. Peterson B, Iglesias R, Zhang J, Wang JC, Lieberman JR. Genetically modified human derived bone marrow cells for posterolateral lumbar spine fusion in athymic rats: beyond conventional autologous bone grafting. Spine 30(3), 283-289; discussion 289-290 (2005).
98. Sheyn D, Ruthemann M, Mizrahi O et al. Genetically modified mesenchymal stem cells induce mechanically stable posterior spine fusion. Tissue Eng. 16(12), 3679-3686 (2010).
99. Wang JC, Kanim LE, Yoo S, Campbell PA, Berk AJ, Lieberman JR. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. J. Bone Joint Surg. Am. 85(5), 905-911 (2003).
100. Lee TC, Ho JT, Hung KS, Chen WF, Chung YH, Yang YL. Bone morphogenetic protein gene therapy using a fibrin scaffold for a rabbit spinal-fusion experiment. Neurosurgery 58(2), 373-380 (2006).
101. Zheng ZM, Dong ZY, Kuang GM et al. [Experimental study on spinal fusion induced by hBMP-4 gene modified tissue engineered bone]. Zhonghua Wai Ke Za Zhi 47(3), 197-201 (2009).
102. Hidaka C, Goshi K, Rawlins B, Boachie-Adjei O, Crystal RG. Enhancement of spine fusion using combined gene therapy and tissue engineering BMP-7-expressing bone marrow cells and allograft bone. Spine 28(18), 2049-2057 (2003).
103. Dumont RJ, Dayoub H, Li JZ et al. Ex vivo bone morphogenetic protein-9 gene therapy using human mesenchymal stem cells induces spinal fusion in rodents. Neurosurgery 51(5), 1239-1244; discussion 1244-1235 (2002).
104. Viggeswarapu M, Boden SD, Liu Y et al. Adenoviral delivery of LIM mineralization protein-1 induces new-bone formation in vitro and in vivo. J. Bone Joint Surg. Am. 83(3), 364-376 (2001).
105. Lu SS, Zhang X, Soo C et al. The osteoinductive properties of Nell-1 in a rat spinal fusion model. Spine J. 7(1), 50-60 (2007).
106. Sheyn D, Kallai I, Tawackoli W et al. Gene-modified adult stem cells regenerate vertebral bone defect in a rat model. Mol. Pharm. 8(5), 1592-1601 (2011).
107. Sheyn D, Pelled G, Zilberman Y et al. Nonvirally engineered porcine adipose tissue-derived stem cells: use in posterior spinal fusion. Stem Cells 26(4), 1056-1064 (2008).
108. Hsu WK, Wang JC, Liu NQ et al. Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model. J. Bone Joint Surg. Am. 90(5), 1043-1052 (2008).
109. Miyazaki M, Zuk PA, Zou J et al. Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model. Spine 33(8), 863-869 (2008).
110. Zhu W, Rawlins BA, Boachie-Adjei O et al. Combined bone morphogenetic protein-2 and-7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J. Bone Mineral Res. 19(12), 2021-2032 (2004).
111. Riew KD, Lou J, Wright NM, Cheng SL, Bae KT, Avioli LV. Thoracoscopic intradiscal spine fusion using a minimally invasive gene-therapy technique. J. Bone Joint Surg. Am. 85-A(5), 866-871 (2003).
112. Smith JO, Aarvold A, Tayton ER, Dunlop DG, Oreffo RO. Skeletal tissue regeneration: current approaches, challenges, and novel reconstructive strategies for an aging population. Tissue Eng. B 17(5), 307-320 (2011).
113. Yuan HA, Brown CW, Phillips FM. Osteoporotic spinal deformity: a biomechanical rationale for the clinical consequences and treatment of vertebral body compression fractures. J. Spinal Disord. Tech. 17(3), 236-242 (2004).
114. Aruna N, Rajeshwari T, Rajangam S. Transmission of the weight through the neural arch of lumbar vertebrae in man. J. Anatom. Soc. India 52(2), 128-131 (2003).
115. Smit TH. The use of a quadruped as an in vivo model for the study of the spine-biomechanical considerations. Eur. Spine J. 11(2), 137-144 (2002).
116. Wilke HJ, Kettler A, Claes LE. Are sheep spines a valid biomechanical model for human spines? Spine 22(20), 2365-2374 (1997).
117. Wilke HJ, Krischak S, Claes L. Biomechanical comparison of calf and human spines. J. Orthop. Res. 14(3), 500-503 (1996).
118. Lim TH, Goel VK, Weinstein JN, Kong W. Stress analysis of a canine spinal motion segment using the finite element technique. J. Biomech. 27(10), 1259-1269 (1994).
119. Palumbo M, Valdes M, Robertson A, Sheikh S, Lucas P. Posterolateral intertransverse lumbar arthrodesis in the New Zealand white rabbit model: I. Surgical anatomy. Spine J. 4(3), 287-292 (2004).
120. Valdes M, Palumbo M, Appel AJ, McAllister S, Ehrlich M. Posterolateral intertransverse lumbar arthrodesis in the New Zealand white rabbit model: II. Operative technique. Spine J. 4(3), 293-299 (2004).
121. Boden SD, Schimandle JH, Hutton WC. An experimental lumbar intertransverse process spinal fusion model. Radiographic, histologic, and biomechanical healing characteristics. Spine 20(4), 412-420 (1995).
122. Morone MA, Boden SD. Experimental posterolateral lumbar spinal fusion with a demineralized bone matrix gel. Spine 23(2), 159-167 (1998).
123. Schimandle JH, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 20(12), 1326-1337 (1995).
124. Grauer JN, Erulkar JS, Patel TC, Panjabi MM. Biomechanical evaluation of the New Zealand white rabbit lumbar spine: a physiologic characterization. Eur. Spine J. 9(3), 250-255 (2000).
125. Erulkar JS, Grauer JN, Patel TC, Panjabi MM. Flexibility analysis of posterolateral fusions in a New Zealand white rabbit model. Spine 26(10), 1125-1130 (2001).
126. Kruyt MC, Van Gaalen SM, Oner FC, Verbout AJ, De Bruijn JD, Dhert WJ. Bone tissue engineering and spinal fusion: the potential of hybrid constructs by combining osteoprogenitor cells and scaffolds. Biomaterials 25(9), 1463-1473 (2004).
127. Drespe IH, Polzhofer GK, Turner AS, Grauer JN. Animal models for spinal fusion. Spine J. 5(6 Suppl. ), 209S-216S (2005).
128. Kandziora F, Pflugmacher R, Scholz M et al. Comparison between sheep and human cervical spines: an anatomic, radiographic, bone mineral density, and biomechanical study. Spine 26(9), 1028-1037 (2001).
129. Kumar N, Kukreti S, Ishaque M, Mulholland R. Anatomy of deer spine and its comparison to the human spine. Anat. Rec. 260(2), 189-203 (2000).
130. Wilke HJ, Kettler A, Wenger KH, Claes LE. Anatomy of the sheep spine and its comparison to the human spine. Anat. Rec. 247(4), 542-555 (1997).
131. Sheng SR, Wang XY, Xu HZ, Zhu GQ, Zhou YF. Anatomy of large animal spines and its comparison to the human spine: a systematic review. Eur. Spine J. 19(1), 46-56 (2010).
132. French RA, Broussard SR, Meier WA et al. Age-associated loss of bone marrow hematopoietic cells is reversed by GH and accompanies thymic reconstitution. Endocrinology 143(2), 690-699 (2002).
133. Sharp A, Zipori D, Toledo J, Tal S, Resnitzky P, Globerson A. Age related changes in hemopoietic capacity of bone marrow cells. Mech. Ageing Dev. 48(1), 91-99 (1989).
134. Kretlow JD, Jin YQ, Liu W et al. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol. 9, 60 (2008).
135. Rodriguez JP, Garat S, Gajardo H, Pino AM, Seitz G. Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics. J. Cell. Biochem. 75(3), 414-423 (1999).
136. Hernigou P, Beaujean F. Bone marrow in patients with pseudarthrosis. A study of progenitor cells by in vitro cloning. Rev. Chir. Orthop. Reparatrice Appar. Mot. 83(1), 33-40 (1997).
137. Mummaneni PV, Haid RW, Rodts GE. Lumbar interbody fusion: state-of-the-art technical advances. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. J. Neurosurg. Spine 1(1), 24-30 (2004).
138. Boden SD. Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute. Spine 27(16 Suppl. 1), S26-S31 (2002).
139. Brodsky AE, Kovalsky ES, Khalil MA. Correlation of radiologic assessment of lumbar spine fusions with surgical exploration. Spine 16(6 Suppl. ), S261-S265 (1991).